How should latent tuberculosis infection be treated in an immunocompetent adult without contraindications?

Treatment of Latent Tuberculosis Infection

For an immunocompetent adult without contraindications, the preferred treatment is 3 months of once-weekly isoniazid plus rifapentine (3HP), which offers excellent efficacy with the highest completion rates due to its short duration. 1

Preferred Regimens (in order of priority)

The 2020 CDC/National Tuberculosis Controllers Association guidelines establish a clear hierarchy 1:

First-Line Choice: 3HP (3 months isoniazid + rifapentine once weekly)

• Strong recommendation with moderate evidence
• Can be given by directly observed therapy (DOT) or self-administered therapy (SAT) 2
• Approximately 4% experience flu-like systemic reactions (fever, headache, dizziness, nausea, muscle pain) typically after the first 3-4 doses, beginning ~4 hours post-ingestion 2
• Only 5% discontinue due to adverse events 2
• Critical caveat: Rifapentine induces metabolism of many medications—monitor drug interactions carefully, especially with hormonal contraceptives (advise barrier method), methadone, and warfarin 2

Second-Line Choice: 4R (4 months daily rifampin)

• Strong recommendation with moderate evidence 1
• Higher adherence rates (38% better completion than longer regimens) 3
• Fewer drug interactions than rifapentine, though still significant with rifampin

Third-Line Choice: 3HR (3 months daily isoniazid + rifampin)

• Conditional recommendation with very low evidence 1
• Network meta-analysis shows 34% better adherence compared to longer regimens 3
• Important warning: Risk of hepatotoxicity may be greater with two drugs combined than either alone 1
• Three times higher rate of permanent discontinuation due to adverse events compared to other regimens 3

Alternative Regimens (when preferred regimens cannot be used)

6H (6 months daily isoniazid)

• Strong recommendation for HIV-negative adults 1
• 41% reduction in TB incidence among HIV-negative patients 3
• Lower completion rates due to longer duration

9H (9 months daily isoniazid)

• Conditional recommendation 1
• Highest risk of grade 3-4 liver toxicity among all regimens 3
• Reserve for situations where rifamycins are absolutely contraindicated

Practical Implementation Algorithm

Step 1: Assess for rifamycin contraindications

• Check all current medications for drug-drug interactions
• Verify no hypersensitivity to rifamycins
• If contraindications exist → proceed to Step 3

Step 2: If no contraindications exist

• Prescribe 3HP (once-weekly for 12 weeks)
• Educate patient about systemic drug reactions occurring after doses 1-4
• Advise women using hormonal contraception to add barrier method
• Perform baseline hepatic enzymes if patient has liver disease risk factors 2

Step 3: If rifamycins contraindicated

• Use 6H (6 months daily isoniazid) as strong alternative
• Monitor for hepatotoxicity more closely
• Emphasize adherence given longer duration

Monitoring Essentials

• Baseline hepatic enzymes indicated for: pre-existing liver disease, regular alcohol use, pregnancy, HIV infection, or concurrent hepatotoxic medications 2
• Educate patients to report: jaundice, dark urine, nausea, vomiting, abdominal pain, unexplained fatigue
• For 3HP specifically: warn about hypotension/syncope (rare: 2 per 1,000 treated) 2
• Use symptom checklists to facilitate timely adverse event recognition 2

Key Pitfalls to Avoid

1. Do not use 9H as first-line: Despite historical use, it has the worst hepatotoxicity profile and lowest completion rates 3
2. Do not overlook drug interactions: Rifamycins are potent enzyme inducers—failure to adjust interacting medications can lead to treatment failures in other conditions 2
3. Do not assume all short regimens are equal: 3RH has significantly higher discontinuation rates due to adverse events compared to 3HP 3
4. Do not forget contraceptive counseling: Rifamycins reduce hormonal contraceptive effectiveness 2